| Literature DB >> 26989154 |
Yi Shen1, Heming Yao2, Ao Li3, Minghui Wang4.
Abstract
Cancer stem cells (CSCs), which have the ability to self-renew and differentiate into various tumor cell types, are a special class of tumor cells. Characterizing the genes involved in CSCs regulation is fundamental to understand the mechanisms underlying the biological process and develop treatment methods for tumor therapy. Recently, much effort has been expended in the study of CSCs and a large amount of data has been generated. However, to the best of our knowledge, database dedicated to CSCs is not available until now. We have thus developed a CSCs database (CSCdb), which includes marker genes, CSCs-related genes/microRNAs and functional annotations. The information in the CSCdb was manual collected from about 13 000 articles. The CSCdb provides detailed information of 1769 genes that have been reported to participate in the functional regulation of CSCs and 74 marker genes that can be used for identification or isolation of CSCs. The CSCdb also provides 9475 annotations about 13 CSCs-related functions, such as oncogenesis, radio resistance, tumorigenesis, differentiation, etc. Annotations of the identified genes, which include protein function description, post-transcription modification information, related literature, Gene Ontology (GO), protein-protein interaction (PPI) information and regulatory relationships, are integrated into the CSCdb to help users get information more easily. CSCdb provides a comprehensive resource for CSCs research work, which would assist in finding new CSCs-related genes and would be a useful tool for biologists. Database URL: http://bioinformatics.ustc.edu.cn/cscdb.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26989154 PMCID: PMC4795926 DOI: 10.1093/database/baw023
Source DB: PubMed Journal: Database (Oxford) ISSN: 1758-0463 Impact factor: 3.451
Figure 1.Database overview. (A) Summary of the database, which shows the resources types and source of the literatures. (B) As showed in the figure, there are 74 marker genes, 1769 related genes and 9475 functional annotations. The functional annotations of marker genes and CSCs-related genes are mainly about 13 categories. (C) The gene number involved in different function is very different.
Figure 2.The web interface of the database. (A) The ‘brows page’ contains four tabs include cell type, markers, function and related gene. Users can choose different tabs and access the content of the database. (B) Users can also choose a marker category in the ‘marker map page’. (C) The ‘gene page’ shows the information of a gene. Interactive network visualization of PPI and microRNA-gene interaction are created by Cytoscape Web plugin (a JavaScript library).
Pathway enrichment analysis of CSCs-related genes (top 25)
| Pathway term | FDR | |
|---|---|---|
| Pathways in cancer | 4.83E−49 | 5.95E−46 |
| Pathways in prostate cancer | 1.26E−23 | 1.55E−20 |
| Cytokine-cytokine receptor interaction | 7.12E−18 | 8.78E−15 |
| Pathways in pancreatic cancer | 1.00E−17 | 1.24E−14 |
| Pathways in chronic myeloid leukemia | 7.85E−17 | 1.33E−13 |
| p53 signaling pathway | 2.24E−14 | 2.76E−11 |
| Pathways in bladder cancer | 2.72E−14 | 3.35E−11 |
| Pathways in colorectal cancer | 6.47E−13 | 7.98E−10 |
| Pathways in melanoma | 8.72E−13 | 1.08E−09 |
| Hematopoietic cell lineage | 8.73E−12 | 1.08E−08 |
| Pathways in glioma | 1.57E−11 | 1.94E−08 |
| Pathways in renal cell carcinoma | 1.81E−11 | 2.24E−08 |
| Focal adhesion | 4.61E−11 | 5.69E−08 |
| ErbB signaling pathway | 6.56E−11 | 8.08E−08 |
| Cell cycle | 1.98E−10 | 2.44E−07 |
| Pathways in acute myeloid leukemia | 2.36E−10 | 2.91E−07 |
| Pathways in endometrial cancer | 3.30E−10 | 4.06E−07 |
| Jak-STAT signaling pathway | 7.99E−10 | 9.85E−07 |
| Apoptosis | 1.32E−09 | 1.62E−06 |
| Neurotrophin signaling pathway | 6.32E−09 | 7.79E−06 |
| Pathways in small cell lung cancer | 7.57E−09 | 9.34E−06 |
| Toll-like receptor signaling pathway | 1.11E−08 | 1.37E−05 |
| MAPK signaling pathway | 4.07E−08 | 5.01E−05 |
| Pathways in non-small cell lung cancer | 1.54E−07 | 1.90E−04 |
| mTOR signaling pathway | 3.13E−07 | 3.86E−04 |